Neurological Institute Outcomes
Brain Tumors
Infratentorial Craniotomy
Survival: Infratentorial Craniotomy
2017 – 2021
The 30- and 180-day survival rates for infratentorial craniotomy were 100% for 2021.
Inpatient Mortality: Infratentorial Craniotomy
2017 – 2021
ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.
There has been only 1 death in patients undergoing infratentorial craniotomy at Cleveland Clinic in the past 5 years, which is below the expected number based on national averages. N = number of infratentorial craniotomies performed for brain tumor per year. In 2021 there were 1.43% inpatient deaths vs an expected mortality of 10.34%.
Average Length of Stay: Infratentorial Craniotomy
2017 – 2021
LOS = length of stay
ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality.
Average length of stay has remained lower than predicted during the past 5 years.
Survival: Infratentorial Craniotomy for Glioma
2017 – 2021
Both the 30- and 180-day survival rates for infratentorial craniotomy for glioma were 100% for 2021.
Survival: Infratentorial Craniotomy for Meningioma
2017 – 2021
Both the 30- and 180-day survival rates for infratentorial craniotomy for meningioma were 100% for 2021.
Survival: Infratentorial Craniotomy for Metastasis
2017 – 2021
Both the 30- and 180-day survival rates for infratentorial craniotomy for brain metastasis were 100% for 2021.
Survival: Infratentorial Craniotomy for Schwannoma
2017 – 2021
Both the 30- and 180-day survival rates for infratentorial craniotomy for Schwannoma were 100% for 2021.